Response to Acute Exercise in Eating Disorders

Description

Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome. This study will develop tasks to characterize cognitive, affective, and biological response to exercise among adolescent and young adult females with EDs and determine whether acute exercise response associates with free-living activity and DEx. This R21 project will provide foundational data to guide research and development of treatments that are more precisely targeted to the symptom of driven exercise and to ultimately improve clinical outcomes associated with EDs.

Conditions

Eating Disorders

Study Overview

Study Details

Study overview

Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome. This study will develop tasks to characterize cognitive, affective, and biological response to exercise among adolescent and young adult females with EDs and determine whether acute exercise response associates with free-living activity and DEx. This R21 project will provide foundational data to guide research and development of treatments that are more precisely targeted to the symptom of driven exercise and to ultimately improve clinical outcomes associated with EDs.

Characterizing Acute Exercise Response in Restrictive Eating Disorders

Response to Acute Exercise in Eating Disorders

Condition
Eating Disorders
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California San Francisco, San Francisco, California, United States, 94158

Madison

University of Wisconsin-Madison, Madison, Wisconsin, United States, 53719

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged 16-25
  • * ED participants must meet full criteria for DSM-5 restrictive-spectrum eating disorders characterized by weight and shape concern, I.e., anorexia nervosa (AN); mild, moderate, or in partial remission), atypical AN, and OSFED -AN type only)
  • * ED participants must be medically stable, and suitable for outpatient treatment
  • * Biological Females, Assigned Female at birth
  • * English Speaking
  • * Those with a medical condition that precludes exercise (e.g., severe asthma) will be excluded for any contraindications
  • * Biological Males, Assigned Male at birth
  • * BMI less than 16 (over 18 years) or less than 75% expected body weight (under 18 years)
  • * Reported intake on Eating Disorder Examination \<1000kcal daily
  • * Current purging \>1x per day
  • * Current regular episodes of objective binge eating (\>1x/wk)
  • * Current self-report of loss-of control eating per the Eating Disorders Examination Interview
  • * ED related hospitalization, partial hospitalization, or residential treatment in the past month
  • * Any endorsed medical concerns related to physical activity (as probed in the phone screening questions regarding cardiovascular, pulmonary, or metabolic disease).
  • * Major medical disorders (e.g., cancer, AIDS)
  • * Physical discomfort or difficulty with blood draws
  • * Psychotic disorders
  • * Intellectual disabilities
  • * Developmental disorders
  • * Active substance use disorder
  • * Current suicidal risk per the Ask Suicide Screening Questionnaire
  • * Pregnancy
  • * Psychiatric medications that have not been stable for at least 4 weeks
  • * Acute sedatives / pain killers (e.g., benzodiazepines, opioids) and prescription stimulants (e.g., methylphenidate, amphetamines) are not permitted for the full day prior to the laboratory session. The noted short-term medication holds only apply to subjects taking the noted medications in cases used to treat ADHD or other psychiatric conditions
  • * Resting heart rate \<50 beats per minute (assessed at screening visit)
  • * Low blood pressure (\<90/60), (assessed at screening visit)
  • * Daily cannabis use
  • * History of light headedness or fainting during blood draws or physical activity
  • * History of chest pain during physical activity
  • * Bone, joint, cardiac, pulmonary, metabolic, or other medical conditions that may be worsened by physical activity (e.g., COPD, diabetes, hypertension) that are not currently addressed via medication or lifestyle change.
  • * Physical disabilities that prohibit task performance (such as blindness or deafness)
  • * Any other condition that the investigator believes might put the participant at risk for negative outcomes
  • * Individuals with a restrictive eating disorder presentation that does not include weight and shape concern (ARFID) or that has primary binge eating (bulimia nervosa)
  • * Indication of health risk associated with exercise on the Physical Activity Readiness Questionnaire

Ages Eligible for Study

16 Years to 25 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Wisconsin, Madison,

Study Record Dates

2025-07-31